IL74497A - Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives - Google Patents

Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives

Info

Publication number
IL74497A
IL74497A IL74497A IL7449785A IL74497A IL 74497 A IL74497 A IL 74497A IL 74497 A IL74497 A IL 74497A IL 7449785 A IL7449785 A IL 7449785A IL 74497 A IL74497 A IL 74497A
Authority
IL
Israel
Prior art keywords
phenyl carbamate
carbamate derivatives
pharmaceutical compositions
compositions containing
certain
Prior art date
Application number
IL74497A
Other languages
English (en)
Other versions
IL74497A0 (en
Inventor
Weinstock Rosin Marta
Tashma Zeev
Chorev Michael
Original Assignee
Proterra Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11055728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL74497(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Proterra Ag filed Critical Proterra Ag
Priority to IL74497A priority Critical patent/IL74497A/xx
Publication of IL74497A0 publication Critical patent/IL74497A0/xx
Priority to PH33465A priority patent/PH23325A/en
Priority to HU86870A priority patent/HU201297B/hu
Priority to IE55886A priority patent/IE58838B1/en
Priority to PT82127A priority patent/PT82127B/pt
Priority to NZ215348A priority patent/NZ215348A/en
Priority to GR860586A priority patent/GR860586B/el
Priority to DE8686102812T priority patent/DE3675408D1/de
Priority to ES552627A priority patent/ES8801193A1/es
Priority to AT86102812T priority patent/ATE58130T1/de
Priority to EP86102812A priority patent/EP0193926B3/en
Priority to FI860914A priority patent/FI87197C/fi
Priority to DE1998175046 priority patent/DE19875046I1/de
Priority to PL1986258224A priority patent/PL146301B1/pl
Priority to KR1019860001491A priority patent/KR940010764B1/ko
Priority to JP61048183A priority patent/JPS61225158A/ja
Priority to DK198600991A priority patent/DK172851B1/da
Priority to CA000503306A priority patent/CA1284501C/en
Priority to AU54284/86A priority patent/AU595504B2/en
Priority to ZA861653A priority patent/ZA861653B/xx
Priority to MYPI87003119A priority patent/MY137602A/en
Priority to US07/320,700 priority patent/US4948807A/en
Publication of IL74497A publication Critical patent/IL74497A/xx
Priority to SG120793A priority patent/SG120793G/en
Priority to HK1302/93A priority patent/HK130293A/en
Priority to CY174894A priority patent/CY1748A/xx
Priority to BR1100327-8A priority patent/BR1100327A/pt
Priority to LU90312C priority patent/LU90312I2/xx
Priority to NL980031C priority patent/NL980031I2/nl
Priority to CY200400004C priority patent/CY2004004I2/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/14—Dithiocarbamic acids; Derivatives thereof
    • C07C333/30—Dithiocarbamic acids; Derivatives thereof having sulfur atoms of dithiocarbamic groups bound to other sulfur atoms
    • C07C333/32—Thiuramsulfides; Thiurampolysulfides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
IL74497A 1985-03-05 1985-03-05 Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives IL74497A (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
IL74497A IL74497A (en) 1985-03-05 1985-03-05 Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
PH33465A PH23325A (en) 1985-03-05 1986-02-28 Phenyl carbamates
HU86870A HU201297B (en) 1985-03-05 1986-03-03 Process for producing phenylcarbamates and pharmaceutical compositions comprising such compounds as active ingredient
IE55886A IE58838B1 (en) 1985-03-05 1986-03-03 Phenyl carbamates
PT82127A PT82127B (pt) 1985-03-05 1986-03-03 Processo para a preparacao de carbamatos de fenilo
NZ215348A NZ215348A (en) 1985-03-05 1986-03-03 Phenyl carbamates and pharmaceutical compositions
GR860586A GR860586B (en) 1985-03-05 1986-03-03 Phenyl- carbamates
DK198600991A DK172851B1 (da) 1985-03-05 1986-03-04 Phenylcarbamater
ES552627A ES8801193A1 (es) 1985-03-05 1986-03-04 Procedimiento para la preparacion de carbamatos de fenilo
PL1986258224A PL146301B1 (en) 1985-03-05 1986-03-04 Method of obtaining phenyl carbaminates
JP61048183A JPS61225158A (ja) 1985-03-05 1986-03-04 フエニルカルバメート類
AT86102812T ATE58130T1 (de) 1985-03-05 1986-03-04 Phenylcarbamate.
EP86102812A EP0193926B3 (en) 1985-03-05 1986-03-04 Phenyl carbamates
FI860914A FI87197C (fi) 1985-03-05 1986-03-04 Foerfarande foer framstaellning av terapeutiskt aktiva fenylkarbamater
DE1998175046 DE19875046I1 (de) 1985-03-05 1986-03-04 Phenylcarbamate
DE8686102812T DE3675408D1 (de) 1985-03-05 1986-03-04 Phenylcarbamate.
KR1019860001491A KR940010764B1 (ko) 1985-03-05 1986-03-04 페닐카르바메이트 및 이것의 염을 제조하는 방법
CA000503306A CA1284501C (en) 1985-03-05 1986-03-05 Phenyl carbamates
AU54284/86A AU595504B2 (en) 1985-03-05 1986-03-05 Phenyl carbamates
ZA861653A ZA861653B (en) 1985-03-05 1986-03-05 Phenyl carbamates
MYPI87003119A MY137602A (en) 1985-03-05 1987-09-25 Phenyl carbamates
US07/320,700 US4948807A (en) 1985-03-05 1989-03-08 Phenyl carbamates
SG120793A SG120793G (en) 1985-03-05 1993-11-07 Phenyl carbamates.
HK1302/93A HK130293A (en) 1985-03-05 1993-11-25 Phenyl carbamates
CY174894A CY1748A (en) 1985-03-05 1994-06-03 Phenyl carbamates
BR1100327-8A BR1100327A (pt) 1985-03-05 1997-04-23 Composições farmacêuticas contendo derivados de carbamato de fenila e certos derivados de carbamato de fenila
LU90312C LU90312I2 (fr) 1985-03-05 1998-11-04 S-N-éthyl-3-[(1-diméthyl-amino)éthyl]-N-méthyl-phénylcarbamate ou un sel pharmaceutiquement acceptable de celui-ci en particulier le tartrate hydrogène
NL980031C NL980031I2 (nl) 1985-03-05 1998-11-05 Fenylcarbamaten.
CY200400004C CY2004004I2 (el) 1985-03-05 2004-10-27 Phenyl carbamates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL74497A IL74497A (en) 1985-03-05 1985-03-05 Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives

Publications (2)

Publication Number Publication Date
IL74497A0 IL74497A0 (en) 1985-06-30
IL74497A true IL74497A (en) 1990-02-09

Family

ID=11055728

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74497A IL74497A (en) 1985-03-05 1985-03-05 Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives

Country Status (25)

Country Link
US (1) US4948807A (enExample)
EP (1) EP0193926B3 (enExample)
JP (1) JPS61225158A (enExample)
KR (1) KR940010764B1 (enExample)
AT (1) ATE58130T1 (enExample)
AU (1) AU595504B2 (enExample)
CA (1) CA1284501C (enExample)
CY (2) CY1748A (enExample)
DE (2) DE3675408D1 (enExample)
DK (1) DK172851B1 (enExample)
ES (1) ES8801193A1 (enExample)
FI (1) FI87197C (enExample)
GR (1) GR860586B (enExample)
HK (1) HK130293A (enExample)
HU (1) HU201297B (enExample)
IE (1) IE58838B1 (enExample)
IL (1) IL74497A (enExample)
LU (1) LU90312I2 (enExample)
MY (1) MY137602A (enExample)
NL (1) NL980031I2 (enExample)
NZ (1) NZ215348A (enExample)
PH (1) PH23325A (enExample)
PL (1) PL146301B1 (enExample)
PT (1) PT82127B (enExample)
ZA (1) ZA861653B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007014973A2 (es) 2005-08-04 2007-02-08 Interquim, S.A. Procedimiento para la obtención de carbamatos de fenilo

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH667001A5 (de) * 1985-09-03 1988-09-15 Hugo Degen Untermatratze.
HU201906B (en) * 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
US5091583A (en) * 1990-05-07 1992-02-25 Air Products And Chemicals, Inc. Tertiary amine catalysts for polurethanes
IT1271679B (it) * 1994-07-18 1997-06-04 Mediolanum Farmaceutici Srl Derivati del fenilcarbammato atti all'impiego come anticolinesterasici
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
US5965571A (en) * 1996-08-22 1999-10-12 New York University Cholinesterase inhibitors for treatment of Parkinson's disease
DE69732984T2 (de) 1996-12-18 2006-02-16 Teva Pharmaceutical Industries Ltd. Aminoindanderivate
US6251938B1 (en) 1996-12-18 2001-06-26 Teva Pharmaceutical Industries, Ltd., Phenylethylamine derivatives
DE69725467T2 (de) * 1996-12-18 2004-07-22 Teva Pharmaceutical Industries Ltd. Phenylethylamin-derivate
US5962535A (en) * 1997-01-17 1999-10-05 Takeda Chemical Industries, Ltd. Composition for alzheimer's disease
EP0952826B1 (en) * 1997-01-17 2001-11-14 Takeda Chemical Industries, Ltd. Idebenone containing combination agent for treating alzheimer's disease
GB9716879D0 (en) * 1997-08-08 1997-10-15 Shire Int Licensing Bv Treatment of attention deficit disorders
US6316023B1 (en) * 1998-01-12 2001-11-13 Novartis Ag TTS containing an antioxidant
EP1133230A4 (en) * 1998-11-23 2004-05-26 Bonnie M Davis DOSAGE FORMULAS FOR ACETYLCHOLINESTERASE INHIBITORS
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
US6534541B1 (en) 1999-10-19 2003-03-18 Novartis Ag Treatment of ocular disorders
CN101519679B (zh) 2000-01-28 2013-11-13 Dsmip资产公司 通过在发酵罐中高密度培养真核微生物来增加含有多烯脂肪酸的脂质的产生
DK1311272T3 (da) * 2000-03-03 2007-02-26 Eisai R&D Man Co Ltd Hidtil ukendte fremgangsmåder hvor der anvendes cholinesteraseinhibitorer
US20030153598A1 (en) * 2000-07-25 2003-08-14 Raymond Pratt Methods for treating Parkinson's disease with cholinesterase inhibitors
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
GB0126378D0 (en) * 2001-11-02 2002-01-02 Oxford Biomedica Ltd Antigen
US20040010038A1 (en) * 2002-02-27 2004-01-15 Eran Blaugrund Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
US7385076B2 (en) 2002-05-31 2008-06-10 Sun Pharmaceutical Industries Limited Process for the preparation of phenylcarbamates
EP2389937B1 (en) 2002-06-14 2018-08-15 Toyama Chemical Co., Ltd. Medicinal composition for improving brain function
CN100408556C (zh) * 2002-10-07 2008-08-06 加利福尼亚大学董事会 通过阻断花生四烯酰乙醇酰胺的水解调节焦虑
CZ20023555A3 (cs) * 2002-10-24 2004-01-14 Léčiva, A.S. Způsob výroby (-)-(S)-3-[1-(dimethylamino)ethyl]fenyl-N-ethyl-N-methylkarbamátu
DE10301851A1 (de) * 2003-01-17 2004-07-29 Lts Lohmann Therapie-Systeme Ag Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
US7521481B2 (en) * 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
WO2005065069A2 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
US7897639B2 (en) * 2003-10-21 2011-03-01 Colucid Pharmaceuticals, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
ATE473967T1 (de) 2003-11-26 2010-07-15 Pfizer Prod Inc Aminopyrazolderivate als gsk-3-inhibitoren
GB0329284D0 (en) * 2003-12-18 2004-01-21 Avecia Ltd Process
GB2409453A (en) * 2003-12-24 2005-06-29 Generics Process for the preparation of aminoalkyl phenylcarbamates
WO2005072713A2 (en) 2004-01-27 2005-08-11 The Feinstein Institute For Medical Research Cholinesterase inhibitors for treating inflammation
CA2555386A1 (en) * 2004-02-19 2005-09-01 Novartis Ag Use of cholinesterase inhibitors for treating vascular depression
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006050359A2 (en) * 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds and methods
RU2393148C2 (ru) * 2004-11-08 2010-06-27 Эмкюр Фармасьютикалз Лимитед Способ получения (s)-3-[(1-диметиламино)этил]-фенил-n-этил-n-метил-карбамата
CA2590533C (en) * 2004-11-23 2010-09-07 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
BRPI0607017B8 (pt) 2005-04-06 2021-05-25 Adamas Pharmaceuticals Inc composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
EP1956904B1 (en) * 2005-12-09 2017-04-12 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Low-dose ladostigil for the treatment of mild cognitive impairment
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof
US7767843B2 (en) * 2006-03-02 2010-08-03 Apotex Pharmachem Inc. Process for the preparation of phenylcarbamates
CA2650711A1 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
DE602006015241D1 (de) * 2006-08-17 2010-08-12 Alembic Ltd Verbessertes verfahren zur herstellung von rivastigmin
WO2008037433A1 (en) 2006-09-29 2008-04-03 Synthon B.V. Process for making aminoalkylphenyl carbamates and intermediates therefor
CA2667553A1 (en) 2006-10-27 2008-05-02 Medivation Neurology, Inc. Methods and combination therapies for treating alzheimer's disease
EP2125709A2 (en) 2007-02-02 2009-12-02 Colucid Pharmaceuticals, Inc. Compounds that inhibit cholinesterase
EP1980552A3 (en) 2007-04-10 2008-10-29 Dr. Reddy's Laboratories Ltd. A process for the preparation of rivastigmine or a salt thereof
CN101707952B (zh) * 2007-04-16 2012-08-29 上海特化医药科技有限公司 一种制备利伐斯的明的方法及其中间体
US7884121B2 (en) 2007-06-11 2011-02-08 Apotex Pharmachem Inc. Process for the preparation of phenylcarbamates
CA2693110A1 (en) * 2007-07-18 2009-01-22 Colucid Pharmaceuticals, Inc. Methods for promoting wakefulness
US8593728B2 (en) * 2009-02-19 2013-11-26 Toyota Motor Engineering & Manufacturing North America, Inc. Multilayer photonic structures
WO2010023535A1 (en) 2008-08-25 2010-03-04 Jubilant Organosys Limited A process for producing (s)-3-[(1-dimethylamino)ethyl] phenyl-n-ethyl-n-methyl-carbamate via novel intermediates
US8247405B2 (en) 2008-12-10 2012-08-21 Conopco, Inc. Skin lightening compositions with acetylcholinesterase inhibitors
CN101580482B (zh) * 2009-05-27 2014-04-23 沈阳药科大学 一种重酒石酸盐卡巴拉汀的制备方法和应用
ES2363395B1 (es) * 2010-01-20 2012-02-23 Farmalider, S.A. Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral.
CN102134206B (zh) * 2010-01-27 2013-11-20 上海京新生物医药有限公司 一种卡巴拉汀的制备方法
EA037187B1 (ru) * 2010-02-09 2021-02-17 Дзе Джонс Хопкинс Юниверсити Способ и композиция для лечения когнитивного расстройства
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
WO2011151669A1 (en) 2010-06-02 2011-12-08 Jubilant Life Sciences Limited Process for producing enantiomerically enriched isomer of 3-(1-aminoethyl) phenyl derivative and employing the same to produce rivastigmine or its pharmaceutically acceptable salt
WO2011159910A2 (en) 2010-06-17 2011-12-22 Codexis, Inc. Biocatalysts and methods for the synthesis of (s)-3-(1-aminoethyl)-phenol
WO2012131699A1 (en) 2011-03-30 2012-10-04 Neon Laboratories Ltd. Process for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate
CN102786441B (zh) * 2011-05-18 2013-11-13 浙江海正药业股份有限公司 利凡斯的明的制备方法、其中间体以及中间体的制备方法
MX2014012374A (es) 2012-04-14 2015-04-17 Intra Cellular Therapies Inc Compuestos organicos.
ES2449215B1 (es) * 2012-09-17 2014-07-14 Galenicum Health S.L. Solución oral de (S)-3-[1-(dimetilamino)etil]fenil N-etil-N-metilcarbamato
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
JP6433482B2 (ja) 2013-03-15 2018-12-05 エージンバイオ， インコーポレイテッド 認知機能を改善するための方法および組成物
US10806717B2 (en) 2013-03-15 2020-10-20 The Johns Hopkins University Methods and compositions for improving cognitive function
WO2015022418A1 (en) 2013-08-16 2015-02-19 Takeda Gmbh Treatment of cognitive impairment with pde4 inhibitor
AU2016268096B2 (en) 2015-05-22 2021-04-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
KR20200035359A (ko) 2018-09-26 2020-04-03 캐딜라 파마슈티클즈 리미티드 리바스티그민 제조용 중간체의 합성

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1905990A (en) * 1931-01-02 1933-04-25 Hoffmann La Roche Disubstituted carbamic acid esters of phenols containing a basic constituent
US2208485A (en) * 1937-04-24 1940-07-16 Hoffmann La Roche Process for the manufacture of disubstituted carbamic acid esters of phenols containing a basic substituent
US2362508A (en) * 1940-12-06 1944-11-14 Merck & Co Inc Therapeutic substances
US2493710A (en) * 1947-03-21 1950-01-03 Hoffmann La Roche Carbamic acid esters
DE1037753B (de) * 1956-07-13 1958-08-28 Rohm & Haas Schaedlingsbekaempfungsmittel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007014973A2 (es) 2005-08-04 2007-02-08 Interquim, S.A. Procedimiento para la obtención de carbamatos de fenilo

Also Published As

Publication number Publication date
CY1748A (en) 1994-06-03
ES552627A0 (es) 1988-01-01
DK172851B1 (da) 1999-08-16
IE860558L (en) 1986-09-05
ES8801193A1 (es) 1988-01-01
JPH0255416B2 (enExample) 1990-11-27
CA1284501C (en) 1991-05-28
DK99186A (da) 1986-09-06
HUT41718A (en) 1987-05-28
IL74497A0 (en) 1985-06-30
DK99186D0 (da) 1986-03-04
KR860007207A (ko) 1986-10-08
PT82127B (pt) 1988-07-01
CY2004004I1 (el) 2009-11-04
EP0193926B1 (en) 1990-11-07
AU5428486A (en) 1986-09-11
NL980031I2 (nl) 1999-03-01
FI87197C (fi) 1992-12-10
JPS61225158A (ja) 1986-10-06
NZ215348A (en) 1990-04-26
HK130293A (en) 1993-12-03
PH23325A (en) 1989-07-14
IE58838B1 (en) 1993-11-17
ZA861653B (en) 1987-10-28
ATE58130T1 (de) 1990-11-15
DE3675408D1 (de) 1990-12-13
NL980031I1 (nl) 1999-01-04
KR940010764B1 (ko) 1994-11-11
FI87197B (fi) 1992-08-31
DE19875046I1 (de) 2003-09-04
CY2004004I2 (el) 2009-11-04
PL146301B1 (en) 1989-01-31
EP0193926B3 (en) 2010-04-28
FI860914L (fi) 1986-09-06
EP0193926A3 (en) 1987-05-13
EP0193926A2 (en) 1986-09-10
FI860914A0 (fi) 1986-03-04
US4948807A (en) 1990-08-14
LU90312I2 (fr) 1999-01-06
MY137602A (en) 2009-02-27
GR860586B (en) 1986-07-07
PT82127A (en) 1986-04-01
HU201297B (en) 1990-10-28
AU595504B2 (en) 1990-04-05

Similar Documents

Publication Publication Date Title
IL74497A (en) Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
MY101791A (en) New benzimidazole derivatives
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
IL85609A0 (en) Phenyl carbamate,its preparation and pharmaceutical compositions containing it
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
FI892454A0 (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
SE8404065D0 (sv) Novel biologically active compounds
IL75794A0 (en) Aminophenol compounds,their preparation and pharmaceutical compositions containing them
HUT46929A (en) Sposob poluchenija aminoglycoside-steroides and pharmaceutical compositions containing them as active components
PH21556A (en) Phenyl nonatetraenoic acid derivatives, pharmaceutical compositions containing the same and method of use thereof
IL77009A0 (en) Biphenylyloxy and biphenylylalkoxy aryl acyl urea derivatives,processes for the preparation thereof and pesticidal compositions containing the same
IL74042A0 (en) N-(naphthyl-alkyl)-hydroxylamines,their production and pharmaceutical compositions containing them
IL77564A (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
BR1100327A (pt) Composições farmacêuticas contendo derivados de carbamato de fenila e certos derivados de carbamato de fenila
IL80436A0 (en) 5-naphthyl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and antidepressant pharmaceutical compositions containing them
PH23671A (en) Aminophenol derivatives and pharmaceutical composition containing them
IL78586A (en) 2,5-bis-(trisubstituted phenyl)-tetrahydrofurans,and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired